To date, the prognostic assessment of intrinsic aggressiveness of meningiomas is based on the histological WHO classification sometimes supported by proliferation markers such as Ki67 and PHH3 [4, 5, 41, 42]. This evidence concerns the gene MKI67 and meningioma.